Pharmaceutical Sales Promotion

Contents

ABSTRACT 2

INTRODUCTION 2

PREVALENT GUIDELINES 3

CURRENT SCENARIO 3

ANALYSIS 4

REFERENCES 5

ABSTRACT

Ever since the advent of medicines as a product, pharmaceuticals have been the centre of limelight when it comes to the ethical codes that bind them. With a constant need of innovation and differentiation as well as the influence of the decision made in the board room on public health, the industry’s practices are increasingly under scrutiny and debate. The primary target of the report is to try and answer questions on whether the prevalent marketing practices draw a line between marketing drugs as medical relievers and selling them like products.

INTRODUCTION

A reconnaissance of the industry shows that however there are guidelines

FDA recommends that firms look to available standards to determine which risks should be included. For example, FDA-approved labeling and Medication Guides, or, a client information sheet, if available for the drug at issue, may be an appropriate starting point to determine which risks should be included in the consumer brief summary and, in fact, may contain the same risk information that should appear in the consumer brief summary. However, some information in patient labeling, such as information found in the Directions for use section (for human prescription drugs) or the client information sheet (for animal drugs), is not necessary to include in the consumer brief summary. Additionally, information not contained in patient labeling, such as information about certain relevant drug risks, might need to be added to the consumer brief

There are currently several types of DTC drug advertisements (Table 1).5,11 One type is the “help-seeking ad,” which provides only information about a medical condition and encourages patients to contact their physician but doesn’t mention a product.5,11 Another category is the “reminder ad,” which includes the product name; this type may provide information about strength, dosage form, or price, but it doesn’t mention the indication or make any claims.5,11 The third and most common type is the “product claim ad,” which mentions the product and its indication and includes efficacy or safety claims.4,5 Each category of ads is subject to different FDA regulatory restrictions (see Table